These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1482147)

  • 1. Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.
    Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Humbert G
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2794-8. PubMed ID: 1482147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.
    Christensson BA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Oqvist B; Norrby SR
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1532-7. PubMed ID: 1510451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
    Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.
    Burman LA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
    J Antimicrob Chemother; 1991 Feb; 27(2):219-24. PubMed ID: 2055812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M; Nagase M; Suzuki Y; Shimomura M; Kakuta S
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men.
    Ljungberg B; Nilsson-Ehle I
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1437-40. PubMed ID: 1510440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem clinical pharmacokinetics.
    Mouton JW; van den Anker JN
    Clin Pharmacokinet; 1995 Apr; 28(4):275-86. PubMed ID: 7648757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of meropenem in patients with liver disease.
    Thyrum PT; Yeh C; Birmingham B; Lasseter K
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S184-90. PubMed ID: 9126692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ofloxacin pharmacokinetics in renal failure.
    Fillastre JP; Leroy A; Humbert G
    Antimicrob Agents Chemother; 1987 Feb; 31(2):156-60. PubMed ID: 3471179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment.
    Patel IH; Sugihara JG; Weinfeld RE; Wong EG; Siemsen AW; Berman SJ
    Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min.
    Kelly HC; Hutchison M; Haworth SJ
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():35-41. PubMed ID: 8543497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of meropenem in healthy beagle dogs receiving intermittent hemodialysis.
    Byun SY; Jeong JW; Choi JH; Lee KP; Youn HY; Maeng HJ; Song KH; Koo TS; Seo KW
    J Vet Pharmacol Ther; 2016 Dec; 39(6):560-565. PubMed ID: 27302674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Thalhammer F; Hörl WH
    Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis.
    Singlas E; Pioger JC; Taburet AM; Colin JN; Fillastre JP
    Clin Pharmacol Ther; 1989 Aug; 46(2):190-7. PubMed ID: 2758728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of meropenem.
    Drusano GL; Hutchison M
    Scand J Infect Dis Suppl; 1995; 96():11-6. PubMed ID: 7652497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
    Gambertoglio JG; Alexander DP; Barriere SL
    Antimicrob Agents Chemother; 1984 Dec; 26(6):845-9. PubMed ID: 6098220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.